ATP7B activity is stimulated by PKCɛ in porcine liver  by Cardoso, Luiza H.D. et al.
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a  b  s  t  r  a  c  t
Copper  is necessary  for  all  organisms  since  it acts  as  a cofactor  in  different  enzymes,  although  toxic  at
high concentrations.  ATP7B  is one  of  two  copper-transporting  ATPases  in  humans,  its vital  role  being
manifested  in  Wilson  disease  due to a mutation  in the  gene  that  encodes  this  pump.  Our  objective  has
been  to determine  whether  pathways  involving  protein  kinase  C  (PKC)  modulate  ATP7B  activity.  Different
isoforms  of  PKC  (, , )  were  found  in Golgi-enriched  membrane  fractions  obtained  from  porcine  liver.
Cu(I)–ATPase  activity  was  assessed  in the presence  of  different  activators  and  inhibitors  of PKC  signaling
pathways.  PMA  (10−8 M),  a PKC  activator,  increased  Cu(I)–ATPase  activity  by 60%, whereas  calphostin  C
and  U73122  (PKC  and PLC  inhibitors,  respectively)  decreased  the  activity  by 40%. Addition  of phosphatase
  decreased  activity  by 60%,  irrespective  of  pre-incubation  with  PMA.  No  changes  were  detected  with
2  M  Ca2+,  whereas  PMA  plus  EGTA  increased  activity.  This enhanced  activity  elicited  by  PMA  decreasedTP7B with  a  speciﬁc  inhibitor  of  PKC  to  levels  comparable  with  those  found  after  phosphatase    treatment,
showing  that the  isoform  is  essential  for activation  of the enzyme.  This  regulatory  phosphorylation
enhanced  Vmax without  modifying  afﬁnities  for ATP and  copper.  It can  be  concluded  that signaling  path-
ways  leading  to DAG  formation  and  PKC  activation  stimulate  the  active  transport  of  copper  by ATP7B,
thus  evidencing  a  central  role  for this  speciﬁc  kinase-mediated  mechanism  in hepatic  copper  handling.. Introduction
Physiologically, copper is an essential heavy metal for almost
ll organisms, being an important cofactor for many different
roteins. However, an excess can also be very toxic, produc-
ng harmful reactive oxygen species (Gupta and Lutsenko, 2009).
herefore, intracellular copper concentration and handling are pre-
isely controlled by different copper-binding proteins. In mammals,
wo proteins are responsible for active copper transport in the
olgi network, Cu(I)–ATPases ATP7A and ATP7B, products of the
enes ATP7A (OMIM 300011) and ATP7B (OMIM 606882). Speciﬁc
utations in these genes cause two different disorders in human
opper homeostasis, the Menkes and Wilson diseases. The past
Abbreviations: BCS, bathocuproine disulfonate; MOPS, 3-(N-morpholino)
ropanesulfonic acid; PMA, phorbol 12-myristate 13-acetate; PPase , protein phos-
hatase .
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three decades have seen characterizations of the catalytic cycle,
structure, localization and copper afﬁnity of Cu(I)–ATPases from
bacteria to humans (Lutsenko et al., 2007). Only in recent years
has the importance of post-translational regulation mediated by
protein kinases emerged, demonstrating that these enzymes reg-
ulate different Cu(I)–ATPases at the protein expression level and
its trafﬁcking (Vanderwerf et al., 2001; Pilankatta et al., 2011;
Veldhuis et al., 2009), copper-binding afﬁnity (Veldhuis et al.,
2011), and the catalytic cycle (Valverde et al., 2008, 2011; Hilário-
Souza et al., 2011). However, in most cases the protein kinases
involved are unknown. Almost all these studies used heterologous
expression and/or overexpression of a Cu(I)–ATPase. Therefore,
major advances in understanding the molecular mechanism by
which protein kinases speciﬁcally regulate Cu(I)–ATPase activities
could be achieved by investigating copper pumps in their native
membrane environments.
We have previously demonstrated that PKA is responsible for
modulating the activities of different Cu(I)–ATPases (Valverde et al.,
2008, 2011; Hilário-Souza et al., 2011), indicating that kinase-
mediated phosphorylation is a key mechanism in the physiological
regulation of active copper transport. It is conceivable that other
kinases are involved, but no description of the regulation of
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u(I)–ATPase by protein kinase C (PKC) seems to be carried out.
KC is a superfamily of serine/threonine kinases involved in many
ifferent signaling events. Distinct isoforms are grouped into three
ubfamilies: (i) classical (, I, II, ), which are activated by Ca2+,
iacylglycerol (DAG) and phospholipids; (ii) novel (	, , 
, ), which
re regulated by DAG and phospholipids, but are independent of
a2+; and (iii) atypical (,/), which do not respond to either Ca2+ or
AG, but are activated by other lipids, protein-protein interactions
r phosphorylation (reviewed by Parker and Murray-Rust, 2004).
We have investigated whether the PLC → PKC signaling pathway
odulates porcine liver Cu(I)-ATPase activity. Among the different
KC isoforms detected in liver, we found that PKC has a key reg-
latory role in activating native ATP7B in its natural membrane
oiety.
. Materials and methods
.1. Reagents
Buffers, protease inhibitors, ATP, U73122, phorbol 12-myristate
3-acetate (PMA) and monoclonal antibody against -actin were
btained from Sigma-Aldrich (St. Louis, MO,  USA). Phosphatase 
as purchased from Millipore Co. (Billerica, MA,  USA). The speciﬁc
KC isoform inhibitors and polyclonal antibodies against ATP7B and
ifferent isoforms of PKC were supplied by Santa Cruz Biotech-
ology (Santa Cruz, CA, USA). Calphostin C was obtained from
albiochem/Merck (Darmstadt, Germany). Nitrocellulose and PVDF
embranes, ECLTM system and secondary antibodies were from
E Healthcare (GE Healthcare, São Paulo, Brazil). Pro-Q Diamond
hosphoprotein Blot Stain and SYPRO Ruby Protein Blot Stain were
urchased from Molecular Probes Invitrogen (Eugene, OR, USA).
orcine livers were obtained from a slaughterhouse supervised by
 veterinarian and under sanitary laws. All other chemical reagents
ere of the highest available purity.
.2. Preparation of membrane fractions
Golgi membrane fractions were obtained as described by
ilário-Souza et al. (2011). The membrane fractions were resus-
ended in MOPS-KOH (pH 7.6) containing 1 mM DTT and stored
n liquid N2. Protein concentration was measured by the Phenol-
eagent method (Lowry et al., 1951), using BSA as the standard.
.3. Identiﬁcation of PKC isoforms by Western blotting
Different samples (20 and 50 g of protein) were separated
y SDS-PAGE (10%) and transferred to nitrocellulose membranes.
embranes were blocked with 5% milk, incubated overnight with
he primary antibody against the PKC isoform (1:1500) at 4 ◦C,
ncubated for 1 h with a horseradish peroxidase-conjugated sec-
ndary antibody at room temperature, and developed with the
CLTM system. After stripping (0.2 M glycine, pH 2.2), the mem-
rane was used to immunodetect other PKC isoforms (,  and ;
:500 dilution). Control loading was carried out using the mono-
lonal antibody against -actin (1:5000).
.4. Cu(I)–ATPase activity
Activity was assayed using 0.25 mg/ml  protein (in membrane
ractions) incubated for 30 min  on ice under two different condi-
ions: (a) assay medium with 100 M ascorbate and 1 mM Na2SO3,
nd (b) assay medium with 250 M BCS – a copper chelator –
ithout the reducing agents. After equilibration at 37 ◦C, the reac-
ion was started by adding 5 mM ATP (Hilário-Souza et al., 2011).
u(I)–ATPase activity was measured as the difference between Pi
eleased under conditions (a) and (b). Reactions were stopped afteriochemistry & Cell Biology 54 (2014) 60–67 61
5 min  with TCA (5% w/v), and ammonium molybdate and Pi was
measured after adding the reducing agent (Fiske and SubbaRow,
1925). Speciﬁc additions aimed to activate or inhibit PKC are indi-
cated in the corresponding ﬁgure legends.
2.5. Inﬂuence of PKC pathway modulators on Cu(I)–ATPase
activity
Modulation of Cu(I)–ATPase activity by PKC pathways was mea-
sured by ATP hydrolysis in the presence of different activators (PMA
and Ca2+) and inhibitors (calphostin, U73122, iPKC and iPKC)
of these pathways. Membrane fractions were pre-incubated for
30 min  with different concentrations of PMA, calphostin C, U73122,
iPKC and iPKC in an ice bath. Concentrations are indicated in the
corresponding ﬁgures and legends. Assays with 2 M free Ca2+ or
2 mM EGTA were used to differentiate between Ca2+-dependent
(conventional) and -independent (novel) PKCs. The 2 M free Ca2+
condition was established using CaCl2 and EGTA according to
Sorenson et al. (1986). In the phosphatase  assay, the membrane
fractions were pre-incubated on ice for 30 min in a medium with
or without PMA. There was further 5 min  incubation at 4 ◦C after
the phosphatase was  added before the reaction was initiated with
ATP.
2.6. Determination of PKC signaling inﬂuence upon ATP7B
enzymatic parameters
To establish whether PKC leads to changes in afﬁnities and/or
Vmax values, ATP7B activity was measured in media containing dif-
ferent concentrations of ATP (at ﬁxed copper) and copper (at ﬁxed
ATP). Since the Cu(I)–ATPase activity was measured in the presence
of contaminant copper only, it was necessary to remove copper
from the samples with BCS as described by Hilário-Souza et al.
(2011).
2.7. Catalytic phosphorylation of ATP7B by [-32P]ATP and decay
of the phosphorylated intermediate
Catalytic phosphorylation of ATP7B was measured as described
by Lowe et al. (2004). The membrane fractions (50 g protein)
were suspended in medium containing 20 mM BIS-TRIS Propane
(pH 6.0), 200 mM KCl and 5 mM MgCl2, and pre-incubated for
30 min  on an ice bath with or without 10−8 M PMA. The reaction (at
0 ◦C) was started by adding [-32P]ATP (ﬁnal concentration 5 M;
1500 cpm/pmol). To follow the phosphoenzyme decay, aliquots
(200 l) were removed at the times shown on the abscissa (10,
30, 60, 300 s) and mixed with 50 l TCA 50% supplied with 1 mM
NaH2PO4 in order to stop the reaction. These quenched samples
were centrifuged for 15 min  at 13,300 × g. The pellet was  washed
twice with 100 l TCA 5% plus NaH2PO4 1 mM,  and resuspended in
40 l acidic sample buffer. The samples were separated by acidic
electrophoresis to avoid breakdown of the acyl-phosphoprotein
(Weber and Osborn, 1969) and the gels exposed to a phos-
phorscreen for analysis using a Phosphor Imager (Cyclone Plus,
Perkin Elmer, Waltham, MA,  USA). The phosphorylated bands
were quantiﬁed with ImageJ software, and each gel was stained
with Coomassie Blue to normalize the phosphorylated protein at
160 kDa by the total protein loaded in each lane.
2.8. Analysis of regulatory phosphorylation of ATP7B by PKC
Samples were incubated in buffer containing 20 mM MOPS-
KOH (pH 7.5), 50 mM K2SO4, 10 mM MgSO4, 4% Glycerol, 10 mM
NaN3, 10 mM NaF, 0.75 mg/ml  protein. They were pre-incubated
for 30 min  in an ice bath with or without 10−8 M PMA  or 10−8 M
calphostin C. After equilibration at 30 ◦C, the reaction was started
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Fig. 1. Stimulation of ATP7B activity by PMA. Membrane fractions were incubated
for 30 min  in an ice bath with different concentrations of PMA, as indicated on
the  abscissa. ATP7B activity was measured as described in Materials and methods.
The control bar shows the activity with no addition of PMA. Data are mean ± SEM
from experiments carried out using different membrane preparations (n = 4).
* Statistically signiﬁcant different from control (p < 0.05) (one-way ANOVA followed
by  Bonferroni post-test).
Fig. 2. Inhibition of ATP7B activity by calphostin C. Membrane fractions were incu-
bated for 30 min  in an ice bath with different concentrations of calphostin C, as
indicated on the abscissa. ATP7B activity was measured as described in Materials and
methods. The control bar shows the activity with no addition of calphostin C. Data2 L.H.D. Cardoso et al. / The International Journ
y addition of ATP (ﬁnal concentration 62.5 M)  and stopped after
0 min  with 40 l of SDS-PAGE sample buffer. The samples were
eparated by SDS-PAGE 10% (Laemmli, 1970), and transferred to
VDF and nitrocellulose membranes; note that the alkaline pH
f the Laemmli’s buffer preserves the regulatory phosphorylation,
hereas the catalytic phosphorylated intermediate is broken. The
embranes were stained with Pro-Q Diamond Phosphoprotein
nd total protein was measured using SYPRO Ruby Protein. An
ttan DIGE Imager (GE Healthcare) scanner analyzed the stained
embranes, and the desired bands were quantiﬁed with ImageJ
oftware. The nitrocellulose membranes were immunoblotted
sing primary antibody against ATP7B (1:500) and ﬂuorochrome-
onjugated secondary antibody. Membranes were analyzed using
canner Odyssey (Li-Cor Biosciences, Lincoln, NK, USA). The avail-
ble commercial antibody against ATP7B was not suitable for
mmunoprecipitation assays using different protocols (A/G protein
garose or magnetic beads), despite the manufacturer’s datasheet.
.9. Alignment and prediction of PKC-target sites
The amino acid sequences of ATP7B from different species as
heep (Q9XT50), mouse (Q64446), human (P35670), rat (Q64535)
nd pig (A5A789) were aligned using the Clustal method (Larkin
t al., 2007) with default parameters and analyzed via Jalview
.81 (Waterhouse et al., 2009). The identiﬁers above indicate the
niProtKB accession numbers (Consortium, 2014). The PKC phos-
horylation sites prediction was carried out using different tools,
n order to maximize the conﬁdence of prediction: Phosphosite
Hornbeck et al., 2012), Scansite 2.0 (Obenauer et al., 2003) and
etPhosK 1.0 (Blom et al., 2004).
.10. Statistical analysis of the data
Each experiment was performed with at least four different
embrane fractions and Cu(I)-ATPase activity was assayed in trip-
icate. When the results are presented as percent of control activity
basal condition with no addition of activators or inhibitors in repli-
ates carried out in parallel), the SEM is calculated from absolute
alues (in nmol Pi × mg  protein−1 × min−1) and then converted to
ercentages. The data were analyzed using one-way ANOVA. The
ost-test analysis signiﬁcance of the differences was veriﬁed by the
ewman–Keuls or Bonferroni post-tests, as indicated in the ﬁg-
re legends (signiﬁcance was set at p < 0.05). Asterisks or different
ower-case letters above the graph bars indicate statistical differ-
nces between groups. Differences between Vmax, Km (ATP curve)
nd K0.5 (free copper curve) values in control conditions vs acti-
ation, or in control conditions vs inhibition of PKC were assessed
ith Student’s t test.
. Results
.1. PMA  increases porcine liver ATP7B activity
PMA, an analog of the physiological diacylglycerol (DAG), an
ntermediate in the PLC → PKC pathway, is an activator of conven-
ional and novel PKC isoforms (Newton and Messing, 2010). Basal
u(I)–ATPase activity (i.e. without exogenous kinase activators
nd/or inhibitors) increased up to 60% after liver Golgi-enriched
embranes had been pre-incubated with raising concentrations of
MA (from 10−11 to 10−6 M)  (Fig. 1), suggesting a PKC-mediated
timulation of the hepatic ATP7B..2. Calphostin C inhibits ATP7B activity
Following from the above results, membrane fractions were
re-incubated under visible light with calphostin C, which bindsare  mean ± SEM from experiments carried out using different membrane prepa-
rations (n = 4). * Statistically signiﬁcant different from control (p < 0.05) (one-way
ANOVA followed by Bonferroni post-test).
irreversibly to the DAG site in the regulatory domain of PKC. The
basal activity of Cu(I)-ATPase decreased 40% with raising concen-
trations of calphostin C (from 10−11 to 10−6 M)  (Fig. 2).
3.3. Phosphatase  abolishes the stimulatory effect of PMA  on
ATP7B activity
Phosphatase  was  added to remove phosphoryl groups from
serine/threonine residues. ATP7B activity decreased by 60% (Fig. 3,
third column), indicating that the basal activity was already under
kinase-mediated phosphorylation(s), which can modulate the cop-
per pump. When phosphatase  was added after the membranes
had been incubated with PMA, ATP7B activity dropped to the
same lower values (Fig. 3, last column), giving support to the view
that PMA-induced activation of the copper pump relies on a PKC-
mediated mechanism.
3.4. PLC is involved in the activation of ATP7B by DAGTo investigate whether PLC-mediated generation of DAG is
involved in the signaling pathway that culminates in increased
ATP7B activity, different concentrations of the PLC inhibitor
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Fig. 3. Phosphatase  inhibits basal ATP7B activity and abolishes the stimulatory
effect of PMA. ATP7B activity was measured in the absence of additions, and in the
presence of PMA  and phosphatase  in the combinations shown on the abscissa.
After 30 min  pre-incubation in the presence or absence of PMA, phosphatase  was
added to the reaction medium for 5 min  before the reaction was  started by ATP
addition. Data are mean ± SEM (n = 4). Different lower-case letters above the bars
indicate statistically signiﬁcant differences (p < 0.05) (one-way ANOVA followed by
Newman–Keuls post-test).
Fig. 4. PLC is involved in the activation of ATP7B by DAG. ATP7B activity was  mea-
sured after 30 min  pre-incubation with the different concentrations of U73122
indicated on the abscissa. Data are mean ± SEM (n = 4). Different lower-case let-
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Fig. 5. Identiﬁcation of different isoforms of PKC in Golgi-enriched liver membrane
fractions. Membrane-associated PKC isoforms were detected by immunoblotting
with speciﬁc antibodies against the ,  and  isoforms. Four different membranes
fractions were analyzed using two  amounts of total protein (20 and 50 g per lane),
as indicated at the bottom of the ﬁgure. Blots were stripped and reprobed for -actin
as  the loading control.
Fig. 6. ATP7B activity is modulated by a PKC from the novel family. Membrane
fractions were pre-incubated with 10−8 M PMA, 2 M free Ca2+ and 2 mM EGTAers above the bars indicate statistically signiﬁcant differences (p < 0.05) (one-way
NOVA followed by Newman–Keuls post-test).
73122 were tested. The inhibitor decreased Cu(I)-ATPase activ-
ty at sub-nanomolar concentrations (Fig. 4), which conﬁrms DAG
roduction by PLC being associated with PKC-mediated stimulation
f ATP7B. It also demonstrates that a membrane-associated PLC is
lready active and contributes to the basal Cu(I)-ATPase activity.
.5. Identiﬁcation of different PKC isoforms in the Golgi
embranes
Western blotting with speciﬁc antibodies was used to determine
hich are the membrane-associated PKC isoforms. Isoforms from
ll PKC families were identiﬁed in four different membrane sam-
les: PKC (conventional), PKC (novel) and PKC (atypical) (Fig. 5).
owever, PKC was not detected (data not shown). We  therefore
ecided to determine which isoform family is responsible for the
ctivation of ATP7B.in the combinations shown on the abscissa. Data are mean ± SEM (n = 4). Differ-
ent lower-case letters above the bars indicate statistically signiﬁcant differences
(p  < 0.05) (one-way ANOVA followed by Newman–Keuls post-test).
3.6. A novel isoform of PKC is responsible for stimulating ATP7B
Since ATP7B activity was  stimulated by PMA, indicating the
involvement of a DAG-dependent PKC, we determined whether a
conventional or a novel PKC isoform is responsible for triggering the
effect on ATPase activity. Only the conventional PKC isoforms are
Ca2+ dependent. ATP7B activity was unaltered when 2 M free Ca2+
(Ca·EGTA buffer) alone was added; moreover, removal of Ca2+ by
EGTA did not modify the stimulatory effect of PMA  (Fig. 6). These
combined experiments show that a PKC isoform from the novel
family is responsible for activating ATP7B.
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Fig. 7. PKC is the isoform responsible for activating ATP7B. ATPase activity was
measured using 500 nM of the speciﬁc inhibitor of PKC (iPKC) in the presence of
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Fig. 8. PMA  leads to increased Vmax of ATP7B, but does not change Km for ATP (at
ﬁx, contaminant copper). Cu(I)–ATPase activity was measured at different concen-
trations of ATP, in the absence and presence of 10−8 M PMA. A Michaelis–Menten
curve was adjusted to the experimental points and the kinetic parameters (see text)
were calculated using the values obtained in different independent ﬁttings (n = 4).
Fig. 9. Calphostin C decreases Vmax of ATP7B, but does not change its K0.5 for cop-
per.  Cu(I)–ATPase activity was measured in the presence of 5 mM ATP at different
concentrations of free copper (BCS·Cu buffer; Hilário-Souza et al., 2011), with and0 M PMA. Data are mean ± SEM (n = 4). Different lower-case letters above the bars
ndicate statistically signiﬁcant differences (p < 0.05) (one-way ANOVA followed by
ewman–Keuls post-test).
.7. PKC is the isoform involved in the stimulation of ATP7B
ctivity
To conﬁrm whether PKC is responsible for activating the
TPase, a speciﬁc PKC inhibitor peptide, iPKC, was used. Pre-
ncubation of the membranes with iPKC decreased PMA-activated
TP7B activity (Fig. 7) to the levels when phosphatase  (Fig. 3)
r U73122 (Fig. 4) was added. This accentuated speciﬁc inhibition
roves that the PKC isoform from the novel family is responsible
or stimulating the liver ATP7B. The lack of an effect with iPKC
data not shown) disproves the involvement of the atypical PKC.
.8. PKC signaling induces increase in ATP7B Vmax for ATP and
opper with no changes in substrate afﬁnities
To determine which changes in enzymatic parameters were
nduced by PKC signaling, ATP7B activity was measured in dif-
erent concentrations of ATP (ﬁxed copper) or copper (ﬁxed
TP). To investigate the inﬂuence of PKC stimulation at dif-
erent Cu(I)–ATPase activity levels, catalysis was assayed with
r without PMA  in different ATP concentrations (Fig. 8).
nalysis of the two curves using the Michaelis–Menten equa-
ion indicates that PMA  treatment raises Vmax (39.2 ± 5.3 nmol
i × mg  protein−1 × min−1 vs 24.1 ± 1.9; p < 0.05), whereas the
m remains unchanged (1.2 ± 0.5 mM in control conditions vs
.5 ± 0.4 in the presence of PMA). The inﬂuence of PKC inhibi-
ion was assessed at different levels of ATP7B activity attained
n different concentrations of copper. The data were ﬁtted by
 Hill sigmoidal curve (Sigma Plot Software). There was no
lteration in the K0.5 for copper (1.2 × 10−17 ± 0.03 × 10−17 M in
ontrol conditions vs 1.0 × 10−17 ± 0.03 × 10−17 M in the presence
f calphostin C); as expected, Vmax decreased from 45.4 ± 4.3 to
6.1 ± 3.6 nmol Pi × mg  protein−1 × min−1 when PKC was  inhibited
y calphostin C (Fig. 9).
.9. PMA  and calphostin C effect on regulatory phosphorylation
f ATP7BTo investigate whether the increase in Cu(I)-ATPase activity
as in fact due to phosphorylation of ATP7B by PKC, assays to
etect the phosphorylation levels of Ser/Thr residues at 160 kDawithout 10−8 M calphostin C. The data were ﬁtted using the Hill sigmoidal equation
(v = Vmax × [free Cu]n/{(K0.5)n + [free Cu]n}. The kinetic parameters (see text) were
calculated using the values obtained in different independent ﬁttings (n = 4).
were carried out. A small, but statistically signiﬁcant, increase of
phosphorylation in the presence of PMA  was seen when compared
with the control condition, whereas calphostin C led to an equiv-
alent decrease in the level of regulatory phosphorylation of ATP7B
(Fig. 10) phosphorylation level. Taken together these data conﬁrm
that PKC modulates ATP7B activity by direct phosphorylation, a sig-
nal that is ampliﬁed downstream to achieve a robust and speciﬁc
response of the pump activity in its native state within the Golgi
membrane environment.
3.10. PMA-induced regulatory phosphorylation did not change
catalytic phosphorylation steps
Finally, we investigated the evolution of catalytic phosphoryla-
tion of ATP7B with time after addition of [-32P]ATP (10, 30, 60 and
300 s). The longer times (60 and 300 s) were chosen to investigate
the inﬂuence of PKC-mediated regulatory phosphorylation on the
decay of the catalytic phosphorylated intermediate at a low micro-
molar ATP concentration, i.e. in a condition of which its breakdown
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Fig. 10. PKC-mediated regulatory phosphorylation of ATP7B. Upper panels: (A)
representative PVDF membrane stained with Pro-Q Diamond, in the following con-
ditions: 10−8 M calphostin C (left), control (middle) and 10−8 M PMA  (right); (B)
representative PVDF membrane stained with SYPRO Ruby in the following con-
ditions: 10−8 M calphostin C (left), control (middle) and 10−8 M PMA (right); (C)
representative nitrocellulose membrane immunoblotted against ATP7B antibody
in  the 3 conditions. Lower panel: quantiﬁcation of the phosphorylated protein at
160 kDa corrected for total protein, taking the control of each experiment (without
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Fig. 11. PKC-mediated phosphorylation did not change the kinetics of phospho-
rylated intermediate decay formed during the ATP7B catalytic cycle. Catalytic
phosphorylation of ATP7B was carried out in the absence (black circles) and pres-
ence (white squares) of 10−8 M PMA. Aliquots were removed at the indicated times
on  the abscissa. Data are mean ± SEM (n = 4) taking the maximal phosphorylation
for each experiment as 100%. The same rate of decay is observed in both conditions,
which were calculated using the exponential decay equation, EPt = EPmax (1 − e−kt),
where k is the rate constant of phosphoenzyme decay. The values given in the text
were calculated from independent ﬁttings.
Table 1
Predicted sites for PKC regulatory phosphorylation in porcine ATP7B sequence.
Residue Score Scansite Score NetPhosK Sequence
Thr20 0.44 0.71 PSQTASGTIRVGGMT
Ser754 0.49 0.51 EALAKLMSLQATEAT
Thr761 0.36 – SLQATEATVVTFGKD
Thr807 0.48 0.51 GKVLEGSTMADESLI
Ser878 0.49 0.51 QQLADRFSGYFVPFI
Thr980 0.52 0.88 EMAHKIKTVMFDKTG
Table 2
Canonical sites for PKC regulatory phosphorylation in mammalian ATP7B
sequences.
Species Sequence Residue
Sheep (Q9XT50) SRRTVWRI Thr1357
Mouse (Q64446) SKRTVRRI Thr1314
Human (P35670) SKRTVRRI Thr1317
Rat (Q64535) SKRTVRRI Thr1305
Pig (A5A789) - - - - - - - -a –alphostin C or PMA) as 100%. The data were analyzed using one-way ANOVA fol-
owed by Newman–Keuls post-test, and different lower-case letters above the bars
ndicate statistically signiﬁcant differences (p < 0.05; n = 12).
s not accelerated by ATP. Fig. 11 depicts the levels of phosphoen-
yme in two conditions (control and with 10−8 M PMA) in all times
ested. The levels of the phosphorylated intermediate were similar
fter 10 s in the absence or presence of PMA, and remained without
tatistical difference throughout phosphoenzyme decay. The sin-
le exponential decay gave similar rate constants in the absence or
resence of PMA  (0.0072 ± 0.0029 and 0.0081 ± 0.0035 s−1, respec-
ively; p > 0.05). These data strongly suggest that the regulatory
KC-mediated phosphorylation should occur in a step after dephos-
horylation of the copper pump, probably at the E2 → E1 transition
uring catalysis (Lowe et al., 2004).
.11. Alignment and prediction of consensus sites for PKC
Using two prediction tools (Scansite 2.0 and NetPhosK 1.0)
nd the Phosphosite database we analyzed different potential
ites for PKC in the porcine sequence, taking into account the
ytoplasmic loops (based in the human ATP7B) and solvent acces-
ibility to select the 6 residues/sites shown in Table 1. However,
he porcine ATP7B sequence is not completely assigned at the N-
nd C-terminus, according to the database UniProtKB. For this
eason, we assessed the alignment of mammalian homologues
ooking for potential PKC target sites in these regions of ATP7B
rom human, mouse, rat, sheep and pig. A canonical sequence for
KC (++XS/TX++; where: +, basic residue; X, any residue; S/T,a The C-terminus of the porcine ATP7B sequence is not yet available. A5A789 is
at  unreviewed state at UniProtKB/TrEMBL.
Ser or Thr residue) was encountered in the C-terminus of four
ATP7B sequences (Table 2). This consensus motif corresponds to
Thr1317 in the human sequence, at the nucleotide binding domain
just before the 7th transmembrane domain. Since the anti-ATP7B
antibody used in Western blot (Fig. 10C) recognizes the C-terminus
domain, it is clear that this region is present in porcine ATP7B.
Altogether, these results are indicative that there are potential
sites for PKC in porcine ATP7B and that the C-terminus of porcine
ATP7B potentially contains the target sequence for PKC.
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. Discussion
In hepatocytes, ATP7B is normally found in trans-Golgi
embranes, but under conditions of copper overload apical
ranslocation of the pump is induced to allow transport of copper to
he biliary capillaries. In a reversible process, the ATPase returns to
he Golgi membranes when intracellular copper homeostasis has
een restored (Guo et al., 2005). This recycling, crucial for copper
xcretion from the body, seems to rely on kinase-mediated mech-
nisms (Vanderwerf et al., 2001; Hasan et al., 2012). Although the
ntire repertoire of kinases regulating Cu(I)–ATPases trafﬁcking is
nknown, highly conserved serine residues that are potential tar-
ets for PKC and PKD – among other kinases – have been identiﬁed
n both ATP7A and ATP7B (Veldhuis et al., 2009; Pilankatta et al.,
009, 2011). Catalysis by ATP7B itself is also regulated by kinase-
ediated phosphorylations (Pilankatta et al., 2009; Hilário-Souza
t al., 2011). An ensemble of interacting kinase signaling pathways
s thought to be involved in regulating ATP7B during early steps
f catalysis and in coupling catalytic phosphorylation to copper
ranslocation through intramolecular and inter-domain commu-
ications (Liu et al., 2010). We  previously showed that ATP7B is
nhibited by PKA (Hilário-Souza et al., 2011), and we have now
emonstrate that another protein kinase modulates Cu(I)-ATPase
ctivity, an important step toward a better understanding of ATP7B
unction.
Stimulation of ATP7B activity in the presence of exogenous PMA
ndicates that mammalian hepatic tissue contains a membrane-
ssociated DAG-dependent PKC isoform functionally coupled to the
opper-transporting ATPase. The basal activity of ATP7B within its
atural membrane environment is already signiﬁcantly stimulated
y PKC (in the absence of exogenous activators), since it inhibited
y calphostin C. The hypothesis of a constitutive activating phos-
horylation status is supported by phosphatase  reducing ATP7B
ctivity to a very low level in the absence of PMA. The phosphatase
-induced drop of activity after PMA  stimulation to the same level
ncountered without PMA  further support the view that activa-
ion of the copper pump is the result of a PKC-mediated regulatory
hosphorylation.
Opposing effects of PKC and PKA seem to constitute a paradigm
or catalysis beyond ATP7B, since the recently-cloned ouabain-
nsensitive renal Na+-ATPase (Rocafull et al., 2012), which is
mportant in the ﬁne-tuning of Na+ transport (Bełtowski et al.,
007), has the same pattern of regulation (Rangel et al., 2005; Lara
t al., 2010), which involves other enzymes in their respective cas-
ades. Inhibition of Cu(I)–ATPase by U73122 shows the presence of
n active PLC in Golgi liver membranes, indicating that any signal
ctivating the PLC → PKC pathway can increase ATP7B activity. The
resence of different PKC isoforms also points for a possible physi-
logical role of signaling pathways mediated by protein G-coupled
eceptors, which might be triggered by hormones and other reg-
latory molecules in response to local copper ﬂuctuations and
inding of the metal to its enzyme sites (Vanderwerf et al., 2001;
anderwerf and Lutsenko, 2002). Thus, it is tempting to propose
hat PKCs have a central role in the kinase-mediated phosphoryla-
ions that elicit responses to control local levels of copper by ATP7B
ransport activity and, ultimately, the subcellular localization of the
ump (Vanderwerf et al., 2001; Hasan et al., 2012).
Ca2+ is a widespread intracellular messenger that exerts its
nﬂuence by activating the classical PKC isoforms (Newton and
essing, 2010). In vitro studies show that different hormones, e.g.
asopressin, angiotensin II, noradrenaline and glucagon (Pittner
nd Fain, 1991) can induce DAG and Ca2+ release in hepatocytes,
hich could stimulate conventional and novel PKCs. The experi-
ents using Ca2+ and PMA  alone or together indicate that signaling
athways leading to Ca2+ release from intracellular stores are not
oupled to processes involved in the stimulation of ATP7B activity,iochemistry & Cell Biology 54 (2014) 60–67
at least not in the liver. Since the inhibition promoted by the spe-
ciﬁc inhibitor peptide iPKC (but not by iPKC) is comparable to
that with calphostin C or phosphatase , and since PKC was not
detected, it is reasonable to propose that PKC is the only PKC iso-
form responsible for activating ATP7B in its natural environment.
The leading role of PKC in regulating hepatic copper handling is
especially interesting in view of the uniqueness of this isoform in
having Golgi binding domains, as also in interacting with proteins
involved in Golgi budding and vesicular trafﬁcking (Lehel et al.,
1995; Csukai et al., 1997). Thus, the regulatory PKC-mediated
phosphorylation coupled to modulation of ATP7B-mediated cop-
per transport seems to be coordinated with forward and retrograde
trafﬁcking of ATP7B to the Golgi network, a copper-induced sub-
cellular redistribution (Vanderwerf et al., 2001). The small increase
in regulatory phosphorylation after PMA that promotes a huge
increment of Cu(I)–ATPase activity is indicative of a very sensitive
and speciﬁc regulatory mechanism involving residues undergo-
ing phosphorylation that may  be ampliﬁed through long-range
intramolecular communications during catalysis (Pilankatta et al.,
2009). The small – though signiﬁcant – inhibition of the regula-
tory phosphorylation of ATP7B by calphostin C, accompanied by
a greater inhibition of ATP7B activity, reinforces the speciﬁc reg-
ulation of copper transport by PKC. The results reﬂect a signal
ampliﬁcation mechanism, one of the pillars of signaling pathways
process: the phosphorylation of a few residues could achieve a
robust and speciﬁc signal transduction (Ubersax and Ferrell, 2007),
which, in the present work, results in 50% PKC-mediated stimula-
tion of ATP7B activity.
The molecular mechanism triggered by PKC seems to acceler-
ate the turnover of ATP7B, since the afﬁnities for copper and ATP
phosphoenzyme decay were unchanged in the presence of inhibitor
or activator of PKC. Thus it is proposed that PKC is responsible
for a direct regulatory phosphorylation of ATP7B activating a cat-
alytical cycle step after dephosphorylation of the enzyme, i.e., it is
reasonable that PKC accelerates the passage of unphosphorylated
enzyme from the E2 to the E1 conformation before copper binding.
This view is supported by the observation that the decay of the cat-
alytic phosphorylated intermediate is not modiﬁed by activation
of PKC by PMA  at a low micromolar ATP concentration, i.e. when
the rate limiting step of the cycle (the E2 → E1 transition) is not
accelerated by ATP.
The alignment analysis and prediction of PKC-target sites – using
different neural networks – in porcine, human, mouse, rat and
sheep ATP7B sequences showed several consensus motifs for PKC
recognition, which provides additional evidence of a PKC-mediated
regulatory phosphorylation of ATP7B. Besides, the existence of a
highly conserved potential site for PKC phosphorylation in the C-
terminus of different mammalian ATP7B sequences – together with
the inhibitory effect of iPCK – suggests that this sequence might
also be present in the porcine protein, giving further support to
the idea of an isoform-speciﬁc PKC signaling mechanism. This site
is located in the large cytoplasmic loop, between the nucleotide
binding domain and the 7th transmembrane motif, in the core
of the protein. Thus, it can be proposed that phosphorylation of
this Thr residue might lead to changes in the protein conforma-
tion, which results in a faster E2 → E1 transition and accelerated
overall turnover. Further studies using a site-directed mutagene-
sis approach should be performed to conﬁrm this prediction, as we
previously have done for Ccc2, the yeast copper ATPase (Valverde
et al., 2008, 2011).
It might be that the regulatory role of PKC demonstrated
here points to a relationship with other kinases, as well as the
complex network of cellular processes in liver that can be inﬂu-
enced by local copper levels under physiological and pathological
conditions. Besides increases of DAG levels, the main effect trig-
gered by glucagon is the stimulation of the PKA-mediated signaling
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athway (Li and Zhuo, 2007), which downregulates ATP7B activity
Hilário-Souza et al., 2011). Thus, PKC seems to be the part-
er of PKA in regulating intracellular copper levels which in turn
ffects the balance among a wide repertoire of kinase-mediated
hosphorylations, as proposed by Kaplan and Lutsenko (2009),
ogether with modiﬁcations of key metabolic pathways. These
ross-talks have important physiological and pathological mani-
estations: (i) hypoinsulinemic rats have high copper content in
heir hepatic cells, the underlying molecular mechanism not yet
eing understood (Failla and Kiser, 1983); (ii) PKC interferes
ith insulin-regulated hepatic carbohydrate and lipid metabolism
Schmitz-Peiffer et al., 1997; Samuel et al., 2007). Unraveling of the
ffect of PKC on ATP7B-mediated copper handling should help elu-
idate these complex interacting signaling pathways, which could
e relevant in understanding the pathogenesis and possible treat-
ent of Wilson disease. Some deleterious gene mutations could be
vercome, at least partially, through manipulation of the kinase-
ediated phosphorylations where PKC has a central role.
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